429 matches for your search in the start-up spotlight
rss
05-May-2025
A record number of over 320 innovators from the international life-science community gathered in Munich for the 17th BioVaria, Europe’s premier event for showcasing commercially attractive inventions and start-ups. A highlight was the BioVaria Startup Pitch & Partner Program, where 10 handpicked ...
Breakthrough antibody therapies target the roots of inflammation and promise breakthroughs for millions of patients
30-Apr-2025
Granite Bio AG has emerged from stealth with $100 million in funding. This includes a $30 million Series A led by founding investors Versant Ventures and Novartis Venture Fund, and a $70 million Series B led by Forbion and Sanofi Ventures. Granite’s pipeline features two first-in-class antibodies ...
Successfully birthed an extinct species
10-Apr-2025
Colossal Biosciences, the world’s only de-extinction company, announces the rebirth of the once extinct dire wolf, the world’s first successfully de-extincted animal. The dire wolf, largely assumed to be a legendary creature made famous from the HBO hit series Game of Thrones, was an American ...
Improving the development of mRNA therapeutics
04-Apr-2025
Wacker Biotech, a contract development and manufacturing organization (CDMO) wholly owned by Wacker Chemie AG, announced a strategic collaboration with RNAV8 Bio, a Boston-based pioneer in mRNA engineering. The collaboration is aimed at progressing the development and production of mRNA-based ...
Isomorphic Labs announces $600m external investment round
03-Apr-2025
Isomorphic Labs, an AI-first drug design and development company, announced it has raised $600 Million in its first external funding round. The financing round is led by Thrive Capital, with participation from GV, and follow-on capital from existing investor, Alphabet. Isomorphic Labs was founded ...
Proceeds to support the clinical development of lead candidate AGT-100216 for the treatment of Charcot-Marie-Tooth (CMT) disease
31-Mar-2025
Augustine Therapeutics NV, a biotechnology company focused on developing new therapies for neuromuscular, neurodegenerative and cardio-metabolic diseases through the inhibition of the cytosolic Histone DeACetylase 6 (HDAC6) enzyme, announced it has successfully completed its Series A financing ...
10-Mar-2025
Callio Therapeutics, a biotechnology company focused on realizing the promise of multi-payload antibody-drug conjugates (ADCs) to improve cancer therapy, today announced its launch with the closing of a $187.0 million Series A financing round. This financing was led by Frazier Life Sciences with ...
Danish biotech replaces cell-based methods with revolutionary cell-free technology, making gene therapy more accessible
28-Feb-2025
Gene therapy's biggest obstacle isn't science - it's manufacturing. While the field races forward with breakthrough treatments, production remains stuck in the 1980s, relying on unpredictable cell-based methods that make therapies costly and slow to develop. Today, Fuse Vectors announces $5.2 ...
4Tissue appoints Dr. Katleen Verleysen as independent chair of the board.
27-Feb-2025
4Tissue, a pioneer in biotechnology that is revolutionizing regenerative medicine, has successfully completed an additional €1.5M funding round, consisting of €1M in equity investments and additional grants. This funding will support the further development of the company’s groundbreaking ...
Working together for a sustainable future
17-Feb-2025
Bürkert Fluid Control Systems has taken a stake in Green Elephant Biotech as a strategic investor so the two companies can work together to develop more efficient, flexible and sustainable cell cultivation processes in the pharmaceutical and biotech industries. This partnership should enable more ...
